نتائج البحث - Priscila Scheinberg

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia

    Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia حسب Phillip Scheinberg, Olga Rios, Priscila Scheinberg, Barbara Weinstein, Colin O. Wu, Neal S. Young

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

    Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia حسب Phillip Scheinberg, Olga Núñez, Barbara Weinstein, Priscila Scheinberg, Colin O. Wu, Neal S. Young

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia

    Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia حسب Phillip Scheinberg, Olga Núñez, Barbara Weinstein, Priscila Scheinberg, Angélique Biancotto, Colin O. Wu, Neal S. Young

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia

    Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia حسب Phillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, Priscila Scheinberg, Barbara Weinstein, Olga Rios, Colin O. Wu, Neal S. Young

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

    Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution حسب Phillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, Priscila Scheinberg, Barbara Weinstein, Maithili M. Daphtary, Olga Rios, Colin O. Wu, Neal S. Young

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study

    Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study حسب Bogdan Dumitriu, Sawa Ito, Xingmin Feng, Melanie R. Nicol, Yunce Muharrem, Sachiko Kajigaya, Joseph Melenhorst, Olga Rios, Priscila Scheinberg, Fariba Chinian, Keyvan Keyvanfar, Minoo Battiwalla, Colin O. Wu, Irina Marić, Liqiang Xi, Mark Raffeld, Pawel Muranski, Danielle M. Townsley, Neal S. Young, Austin John Barrett, Phillip Scheinberg

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: